111 related articles for article (PubMed ID: 16194660)
1. Doctors and the drug industry: reader feedback.
Adams CD
Am J Med; 2005 Oct; 118(10):1177; author reply 1178. PubMed ID: 16194660
[No Abstract] [Full Text] [Related]
2. Doctors and the drug industry: reader feedback.
Nardone DA
Am J Med; 2005 Oct; 118(10):1176-7; author reply 1177. PubMed ID: 16194658
[No Abstract] [Full Text] [Related]
3. Doctors and the drug industry: reader feedback.
Warrier R; Houghton B
Am J Med; 2005 Oct; 118(10):1175-6; author reply 1176. PubMed ID: 16194656
[No Abstract] [Full Text] [Related]
4. Doctors and the drug industry: how can we handle potential conflicts of interest?
Alpert JS
Am J Med; 2005 Feb; 118(2):99-100. PubMed ID: 15694888
[No Abstract] [Full Text] [Related]
5. Doctors and drug companies--scrutinizing influential relationships.
Campbell EG
N Engl J Med; 2007 Nov; 357(18):1796-7. PubMed ID: 17978288
[No Abstract] [Full Text] [Related]
6. [Medical doctors and pharmaceutical industry].
de Francisco AL
Nefrologia; 2004; 24(5):393-4. PubMed ID: 15648899
[No Abstract] [Full Text] [Related]
7. Resident and fellow section. Conflicts of interest between physicians and the pharmaceutical industry: focus on headache medicine.
Rubin EB; Bernat JL
Headache; 2008; 48(10):1545-9. PubMed ID: 19076654
[No Abstract] [Full Text] [Related]
8. The physician and the pharmaceutical industry: both must keep the patient's interests at heart.
Ravindran GD
Issues Med Ethics; 1999; 7(1):21-2. PubMed ID: 16320467
[No Abstract] [Full Text] [Related]
9. Cash interests taint drug advice.
Taylor R; Giles J
Nature; 2005 Oct; 437(7062):1070-1. PubMed ID: 16237402
[No Abstract] [Full Text] [Related]
10. Medical students protest perks from drug companies.
Opar A
Nat Med; 2006 Oct; 12(10):1104. PubMed ID: 17024192
[No Abstract] [Full Text] [Related]
11. Transparency urged over research payments.
Check E
Nature; 2007 Aug; 448(7155):738. PubMed ID: 17700667
[No Abstract] [Full Text] [Related]
12. Conflict of interest in the physician interface with the biomedical industry.
Minnigan H; Chisholm CD
Emerg Med Clin North Am; 2006 Aug; 24(3):671-85. PubMed ID: 16877136
[TBL] [Abstract][Full Text] [Related]
13. [New conduct recommendations for physicians cooperating with the pharmaceutical industry? The "FS Codex" and its consequences for physicians].
Häser I; Hofmann A
Anaesthesist; 2005 Mar; 54(3):263-7. PubMed ID: 15719243
[No Abstract] [Full Text] [Related]
14. Conflict of interest rules seen by some as too stringent.
Willyard C
Nat Med; 2009 Jul; 15(7):709. PubMed ID: 19584838
[No Abstract] [Full Text] [Related]
15. Conflicts of interest.
Ripps RA
Conn Med; 2009 Jan; 73(1):37-8. PubMed ID: 19248573
[No Abstract] [Full Text] [Related]
16. Gifts to physicians from the pharmaceutical industry: an ethical analysis.
Marco CA; Moskop JC; Solomon RC; Geiderman JM; Larkin GL
Ann Emerg Med; 2006 Nov; 48(5):513-21. PubMed ID: 17052550
[TBL] [Abstract][Full Text] [Related]
17. [Doctors and the drug industry].
Gudmundsson S
Laeknabladid; 2005 Mar; 91(3):234. PubMed ID: 16155323
[No Abstract] [Full Text] [Related]
18. [New contract recommendations for physicians cooperating with the pharmaceutical industry? The "FS Codex" and its consequences for physicians].
Häser I; Hofmann A
Orthopade; 2005 Mar; 34(3):263-4, 266. PubMed ID: 16247838
[No Abstract] [Full Text] [Related]
19. Doctors with ties to device makers.
N Y Times Web; 2005 Sep; ():A14. PubMed ID: 16231461
[No Abstract] [Full Text] [Related]
20. Physicians and pharma--an unholy alliance?
Borders JM
J Ky Med Assoc; 2007 Apr; 105(4):177-8. PubMed ID: 17494281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
